electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2024 Financial Results on Wednesday, March 12, 2025GlobeNewsWire • 03/06/25
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid WithdrawalGlobeNewsWire • 02/27/25
electroCore (ECOR) Is a Great Choice for 'Trend' Investors, Here's WhyZacks Investment Research • 02/12/25
electroCore to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceGlobeNewsWire • 02/04/25
electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and WellnessGlobeNewsWire • 12/17/24
electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21GlobeNewsWire • 11/14/24
Strength Seen in electroCore (ECOR): Can Its 6.0% Jump Turn into More Strength?Zacks Investment Research • 11/11/24
Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) is effective in accelerating United States Air Force Pilot TrainingGlobeNewsWire • 09/10/24
electroCore to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceGlobeNewsWire • 09/04/24
electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq RulesGlobeNewsWire • 06/03/24
Wall Street Analysts See a 251.77% Upside in electroCore (ECOR): Can the Stock Really Move This High?Zacks Investment Research • 05/30/24